Hauptseite > Publikationsdatenbank > Preparation of radiolabeled sulfamoyl fluorides by SuFEx 18F/19F isotopic exchange and assessment of their in vivo stability > print

001     1026459
005     20250203103352.0
037 _ _ |a FZJ-2024-03408
041 _ _ |a English
100 1 _ |a Hoffmann, Chris
|0 P:(DE-Juel1)180770
|b 0
|e Corresponding author
111 2 _ |a 25th International Symposium on Radiopharmaceutical Sciences
|g ISRS2023
|c Honolulu, USA
|d 2023-05-22 - 2023-05-26
|w USA
245 _ _ |a Preparation of radiolabeled sulfamoyl fluorides by SuFEx 18F/19F isotopic exchange and assessment of their in vivo stability
260 _ _ |c 2023
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a Other
|2 DataCite
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a LECTURE_SPEECH
|2 ORCID
336 7 _ |a Conference Presentation
|b conf
|m conf
|0 PUB:(DE-HGF)6
|s 1716544325_30286
|2 PUB:(DE-HGF)
|x After Call
520 _ _ |a Objectives: Aryl fluorosulfates (FO 2 S-O-) and disubstituted sulfa-moyl fluorides (FO 2S-N-) often possess high hydrolytic stability and arewidely used in chemical biology and drug design. Recently we reporteda protocol for convenient preparation of radiolabeled aryl fluorosul-fates with high molar activity via fast 18 F/19 F isotopic exchange [1]. Theaim of the present work was to study the suitability of this procedurefor radiofluorination of sulfamoyl fluorides. To this end, the procedurewas applied to N-sulfamoylated indole and carbazole as well as tothree protected amino acids (Boc-Trp(SO2 F)-OMe 1, Boc-His(SO2F)-OMe 2 and Boc-2,3-DH-Trp(SO2 F)-OMe 3). Additionally, the in vivostability of the radiolabeled tryptophan derivative Boc-Trp([18 F]SO2F)-OMe ([18 F]1) was evaluated.Methods: Aqueous [18 F]fluoride was loaded onto an anionexchange QMA cartridge and eluted with Et 4NOH (10 μmol) inMeOH (1 mL). MeOH was evaporated, a solution of the correspondingsubstrate (31–125 nmol) in MeCN (500 μL) was added and the reactionmixture was stirred for 7 min at 40 °C. Thereafter, H2 O (1 mL) wasadded and radiochemical conversions (RCCs) were determined byradio-HPLC. [ 18 F]1 was isolated by solid phase extraction using aStrataX C18 cartridge. The tracer was formulated in Tween® 20 (200 μL)and 1 mm sodium phosphate buffer (2 μL; pH 7.2) and subjected to apreclinical evaluation in healthy mice using μPET.Results: Radiolabeled N–sulfamoyl fluorides of carbazole andindole were prepared in RCCs of 72 ± 2% and 86 ± 2%, respectively.FO 2SN-functionalized protected tryptophan 1 (RCC: 68 ± 5%), histidine2 (RCC: 3 ± 1%) and 2,3-dihydroxy-tryptophan 3 (RCC: 34%; 60°C,14 min), were also successfully radiofluorinated. Boc-Trp([18 F]SO2F)-OMe [18 F]1 was isolated in activity yields of 24 ± 2% with aradiochemical purity of 99% (n = 3) within 70 min using 12.5 μg (31 nmol) of precursor. In μPET experiments, the radiolabeled productshowed very low radioactivity accumulation in bones, indicating a lackof significant in vivo defluorination. The study also demonstratedalmost exclusive hepatobiliary elimination of the tracer, presumablyowing to its very high lipophilicity.Conclusions: The SuFEx protocol developed for radiolabeling offluorosulfates was successfully applied for the simple and fastpreparation of 18 F-labeled sulfamoyl fluorides. High metabolic stabilityof Boc-Trp(SO2 [ 18F]F)-OMe underlines the suitability of this class ofradiolabeled compounds as PET-probes for in vivo imaging.Reference[1] Walter N., Bertram J., Drewes B., Bahutski V., Timmer M., SchützM. B., Krämer F., Neumaier F., Endepols H., Neumaier B.,Zlatopolskiy B. D., European Journal of Medicinal Chemistry2022, 237, 114383.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
700 1 _ |a Bertram, Jan
|0 P:(DE-Juel1)191040
|b 1
700 1 _ |a Endepols, Heike
|0 P:(DE-Juel1)180330
|b 2
700 1 _ |a Zlatopolskiy, Boris
|0 P:(DE-Juel1)185610
|b 3
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 4
|e Corresponding author
856 4 _ |u https://juser.fz-juelich.de/record/1026459/files/1-s2.0-S0969805123002068-main.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/1026459/files/1-s2.0-S0969805123002068-main.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/1026459/files/1-s2.0-S0969805123002068-main.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/1026459/files/1-s2.0-S0969805123002068-main.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/1026459/files/1-s2.0-S0969805123002068-main.jpg?subformat=icon-640
|x icon-640
|y Restricted
909 C O |o oai:juser.fz-juelich.de:1026459
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)180770
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)191040
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)180330
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)185610
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)166419
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2024
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a conf
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21